Dr. Evans is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4860 Y St
Suite 3500
Sacramento, CA 95817Phone+1 916-734-5154Fax+1 916-734-8094- Is this information wrong?
Summary
- I am a board certified urologist, with a fellowship specializing in oncology. I focus on treating prostate, bladder, kidney and testicular cancers. I am Professor and Chairman of the UC Davis School of Medicine Department of Urologic Surgery and President of the Society of Urologic Oncology. I have an active molecular biology laboratory focused on prostate cancer.
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 1995 - 1997
- University of California (San Francisco)Residency, Urology, 1991 - 1995
- University of California (San Francisco)Residency, Surgery, 1990 - 1991
- Madigan Army Medical CenterInternship, Transitional Year, 1986 - 1987
- Geisel School of Medicine at DartmouthClass of 1986
Certifications & Licensure
- CA State Medical License 1990 - 2024
- TX State Medical License 1996 - 1998
- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
- Fellow (FACS) American College of Surgeons
- Super Doctor SuperDoctors.com
Clinical Trials
- Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer Start of enrollment: 2016 Jun 22
Publications & Presentations
PubMed
- IGFBP3 promotes resistance to Olaparib via modulating EGFR signaling in advanced prostate cancer.Amy R Leslie, Shu Ning, Cameron M Armstrong, Leandro S D'Abronzo, Masuda Sharifi, Zachary A Schaaf, Wei Lou, Chengfei Liu, Christopher P Evans, Alan P Lombard, Allen C...> ;Iscience. 2024 Feb 16
- 1 citationsCardiovascular Effects of GnRH Antagonists Compared With Agonists in Prostate Cancer: A Systematic Review.Adam J Nelson, Renato D Lopes, Hwanhee Hong, Kaiyuan Hua, Susan Slovin, Sean Tan, Jan Nilsson, Deepak L Bhatt, Shaun G Goodman, Christopher P Evans, Noel W Clarke, Nea...> ;JACC. Cardiooncology. 2023 Oct 1
- 1 citationsSecondary Bladder Cancer After Prostate Cancer Treatment: An Age-matched Comparison Between Radiation and Surgery.Steven Monda, Manolis Pratsinis, Hansen Lui, Onika Noel, Thenappan Chandrasekar, Christopher P Evans, Marc A Dall'Era> ;European Urology Focus. 2023 Sep 16
- Join now to see all
Journal Articles
- KDM8/JMJD5 as a Dual Coactivator of AR and PKM2 Integrates AR/EZH2 Network and Tumor Metabolism in CRPCChristopher Evans, MD, Nature
Press Mentions
- Early Career Investigator Receives Federal Funding to Research Lethal Prostate CancerJune 11th, 2021
- Drug ISRIB Is a Memory Enhancer, Anti Cancer Agent, Protects Hearing and Perhaps Has Anti Aging EffectsDecember 27th, 2020
- Research Finds ‘Achilles Heel’ for Aggressive Prostate CancerMay 14th, 2018
Grant Support
- Neurotrophins And Tyrosine Kinases In Prostate CancerNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2006
Professional Memberships
- Member
- Fellow
Hospital Affiliations
- UC Davis Medical CenterSacramento, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: